nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—osteoarthritis—Prednisone—Crohn's disease	0.386	1	CpDpCtD
Glucosamine—IFNG—Crohn's disease	0.331	0.705	CbGaD
Glucosamine—TNF—Crohn's disease	0.138	0.295	CbGaD
Glucosamine—NFKB2—mammalian vulva—Crohn's disease	0.00263	0.0946	CbGeAlD
Glucosamine—Azacitidine—DNMT3A—Crohn's disease	0.00259	1	CrCbGaD
Glucosamine—NFKB2—lymphoid tissue—Crohn's disease	0.00234	0.084	CbGeAlD
Glucosamine—NFKB2—digestive system—Crohn's disease	0.00231	0.083	CbGeAlD
Glucosamine—MMP9—mouth—Crohn's disease	0.00227	0.0816	CbGeAlD
Glucosamine—IFNG—epithelium—Crohn's disease	0.00206	0.0739	CbGeAlD
Glucosamine—IFNG—skin of body—Crohn's disease	0.00195	0.0703	CbGeAlD
Glucosamine—IFNG—lymphoid tissue—Crohn's disease	0.00158	0.0569	CbGeAlD
Glucosamine—IFNG—digestive system—Crohn's disease	0.00156	0.0562	CbGeAlD
Glucosamine—TNF—lymph node—Crohn's disease	0.00134	0.0481	CbGeAlD
Glucosamine—MMP9—epithelium—Crohn's disease	0.00132	0.0475	CbGeAlD
Glucosamine—NFKB2—lymph node—Crohn's disease	0.00132	0.0474	CbGeAlD
Glucosamine—MMP9—smooth muscle tissue—Crohn's disease	0.00127	0.0457	CbGeAlD
Glucosamine—MMP9—skin of body—Crohn's disease	0.00126	0.0451	CbGeAlD
Glucosamine—MMP9—lymphoid tissue—Crohn's disease	0.00102	0.0366	CbGeAlD
Glucosamine—MMP9—digestive system—Crohn's disease	0.001	0.0361	CbGeAlD
Glucosamine—IFNG—lymph node—Crohn's disease	0.000893	0.0321	CbGeAlD
Glucosamine—NFKB2—Betamethasone—Prednisone—Crohn's disease	0.000842	0.5	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Prednisone—Crohn's disease	0.000842	0.5	CbGdCrCtD
Glucosamine—MMP9—lymph node—Crohn's disease	0.000573	0.0206	CbGeAlD
Glucosamine—CYP2C19—digestive system—Crohn's disease	0.00045	0.0162	CbGeAlD
Glucosamine—CYP2E1—lymphoid tissue—Crohn's disease	0.000335	0.012	CbGeAlD
Glucosamine—CYP2E1—digestive system—Crohn's disease	0.000331	0.0119	CbGeAlD
Glucosamine—IFNG—ATF-2 transcription factor network—IL6—Crohn's disease	6.53e-05	0.000577	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IFNG—Crohn's disease	6.52e-05	0.000576	CbGpPWpGaD
Glucosamine—MMP9—TWEAK Signaling Pathway—IL6—Crohn's disease	6.5e-05	0.000574	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—STAT3—Crohn's disease	6.48e-05	0.000572	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—TNF—Crohn's disease	6.45e-05	0.000569	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—TNF—Crohn's disease	6.41e-05	0.000566	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL1B—Crohn's disease	6.4e-05	0.000566	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—Crohn's disease	6.35e-05	0.000561	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—ITGA4—Crohn's disease	6.34e-05	0.00056	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	6.32e-05	0.000558	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CARD9—Crohn's disease	6.32e-05	0.000558	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	6.31e-05	0.000558	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—STAT3—Crohn's disease	6.3e-05	0.000556	CbGpPWpGaD
Glucosamine—IFNG—Immune System—DEFA5—Crohn's disease	6.28e-05	0.000554	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IFNGR2—Crohn's disease	6.28e-05	0.000554	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—IFNG—Crohn's disease	6.23e-05	0.00055	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	6.16e-05	0.000544	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL18—Crohn's disease	6.14e-05	0.000542	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—CRP—Crohn's disease	6.02e-05	0.000532	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 cascade initiated on plasma membrane—IL6—Crohn's disease	6.02e-05	0.000531	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—TAB1—Crohn's disease	5.98e-05	0.000528	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—IL6—Crohn's disease	5.97e-05	0.000527	CbGpPWpGaD
Glucosamine—NFKB2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Crohn's disease	5.96e-05	0.000526	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—TNF—Crohn's disease	5.88e-05	0.000519	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 dependent cascade initiated on endosome—IL6—Crohn's disease	5.85e-05	0.000517	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—IL6—Crohn's disease	5.85e-05	0.000517	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—SOCS1—Crohn's disease	5.85e-05	0.000516	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—IL6—Crohn's disease	5.84e-05	0.000515	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—ICAM1—Crohn's disease	5.83e-05	0.000515	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL1B—Crohn's disease	5.81e-05	0.000513	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—ALB—Crohn's disease	5.81e-05	0.000513	CbGpPWpGaD
Glucosamine—IFNG—Interferon Signaling—TYK2—Crohn's disease	5.75e-05	0.000508	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—UBE2D1—Crohn's disease	5.7e-05	0.000503	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—IL6—Crohn's disease	5.7e-05	0.000503	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—IL6—Crohn's disease	5.66e-05	0.0005	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—IL6—Crohn's disease	5.65e-05	0.000499	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 9 (TLR9) Cascade—IL6—Crohn's disease	5.65e-05	0.000499	CbGpPWpGaD
Glucosamine—NFKB2—MyD88:Mal cascade initiated on plasma membrane—IL6—Crohn's disease	5.55e-05	0.00049	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—SOCS1—Crohn's disease	5.54e-05	0.000489	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—ICAM1—Crohn's disease	5.54e-05	0.000489	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—RIPK2—Crohn's disease	5.52e-05	0.000488	CbGpPWpGaD
Glucosamine—IFNG—Interferon Signaling—JAK2—Crohn's disease	5.49e-05	0.000485	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL2RA—Crohn's disease	5.45e-05	0.000481	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IFNG—Crohn's disease	5.44e-05	0.000481	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—STAT3—Crohn's disease	5.34e-05	0.000472	CbGpPWpGaD
Glucosamine—NFKB2—MyD88-independent cascade—IL6—Crohn's disease	5.33e-05	0.00047	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—Crohn's disease	5.3e-05	0.000468	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IFNG—Crohn's disease	5.3e-05	0.000468	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—RASGRP1—Crohn's disease	5.26e-05	0.000464	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—PTGS2—Crohn's disease	5.22e-05	0.000461	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—RASGRP1—Crohn's disease	5.21e-05	0.00046	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	5.2e-05	0.000459	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TAB1—Crohn's disease	5.14e-05	0.000454	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—TLR4—Crohn's disease	5.13e-05	0.000453	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CARD9—Crohn's disease	5.12e-05	0.000452	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TAB1—Crohn's disease	5.1e-05	0.00045	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CXCL8—Crohn's disease	5.06e-05	0.000447	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—SMAD3—Crohn's disease	5.05e-05	0.000446	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—GPX4—Crohn's disease	5.05e-05	0.000446	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—TYK2—Crohn's disease	5.04e-05	0.000445	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	5.03e-05	0.000444	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	5.02e-05	0.000443	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—NOD2—Crohn's disease	5.01e-05	0.000442	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—IL6—Crohn's disease	4.97e-05	0.000439	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—IL6—Crohn's disease	4.94e-05	0.000436	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	4.9e-05	0.000433	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL1B—Crohn's disease	4.85e-05	0.000429	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—JAK2—Crohn's disease	4.81e-05	0.000425	CbGpPWpGaD
Glucosamine—NFKB2—Activated TLR4 signalling—IL6—Crohn's disease	4.79e-05	0.000423	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—IL6—Crohn's disease	4.74e-05	0.000419	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—TYK2—Crohn's disease	4.74e-05	0.000419	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL1B—Crohn's disease	4.73e-05	0.000418	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—ICAM1—Crohn's disease	4.73e-05	0.000417	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—SOCS1—Crohn's disease	4.72e-05	0.000417	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—STAT3—Crohn's disease	4.66e-05	0.000411	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TNF—Crohn's disease	4.65e-05	0.00041	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—ALB—Crohn's disease	4.62e-05	0.000408	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NOD1—Crohn's disease	4.61e-05	0.000407	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IFNG—Crohn's disease	4.59e-05	0.000406	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—TNF—Crohn's disease	4.59e-05	0.000405	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TLR4—Crohn's disease	4.57e-05	0.000403	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL10—Crohn's disease	4.53e-05	0.0004	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—JAK2—Crohn's disease	4.52e-05	0.000399	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 4 (TLR4) Cascade—IL6—Crohn's disease	4.51e-05	0.000398	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IFNG—Crohn's disease	4.44e-05	0.000392	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL6—Crohn's disease	4.4e-05	0.000389	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—ICAM1—Crohn's disease	4.38e-05	0.000387	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL6—Crohn's disease	4.32e-05	0.000381	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CXCL8—Crohn's disease	4.27e-05	0.000377	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IFNG—Crohn's disease	4.21e-05	0.000372	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CCR6—Crohn's disease	4.18e-05	0.000369	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IL6—Crohn's disease	4.12e-05	0.000364	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—IL1B—Crohn's disease	4.1e-05	0.000362	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IL1B—Crohn's disease	4.1e-05	0.000362	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	4.06e-05	0.000359	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—PTGS2—Crohn's disease	4.04e-05	0.000357	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—IL6—Crohn's disease	4.01e-05	0.000354	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—TLR4—Crohn's disease	4.01e-05	0.000354	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—IL6—Crohn's disease	3.98e-05	0.000351	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL1B—Crohn's disease	3.96e-05	0.00035	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	3.89e-05	0.000344	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—TYK2—Crohn's disease	3.84e-05	0.000339	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PTPN2—Crohn's disease	3.83e-05	0.000338	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ACKR2—Crohn's disease	3.82e-05	0.000337	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—RBX1—Crohn's disease	3.78e-05	0.000334	CbGpPWpGaD
Glucosamine—TNF—Signaling events mediated by HDAC Class I—STAT3—Crohn's disease	3.78e-05	0.000334	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL1B—Crohn's disease	3.76e-05	0.000332	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—ICAM1—Crohn's disease	3.76e-05	0.000332	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL6—Crohn's disease	3.75e-05	0.000331	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NOD1—Crohn's disease	3.73e-05	0.00033	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL6—Crohn's disease	3.7e-05	0.000327	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—JAK2—Crohn's disease	3.66e-05	0.000324	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MLN—Crohn's disease	3.62e-05	0.000319	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CRP—Crohn's disease	3.56e-05	0.000314	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—STAT3—Crohn's disease	3.53e-05	0.000312	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TNF—Crohn's disease	3.52e-05	0.000311	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CXCL8—Crohn's disease	3.48e-05	0.000307	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TLR4—Crohn's disease	3.41e-05	0.000301	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL6—Crohn's disease	3.4e-05	0.000301	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CCR6—Crohn's disease	3.39e-05	0.000299	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL1B—Crohn's disease	3.34e-05	0.000295	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IFNG—Crohn's disease	3.33e-05	0.000294	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—STAT3—Crohn's disease	3.32e-05	0.000293	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—UBE2D1—Crohn's disease	3.32e-05	0.000293	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TAGAP—Crohn's disease	3.31e-05	0.000292	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—Crohn's disease	3.27e-05	0.000289	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—RIPK2—Crohn's disease	3.22e-05	0.000284	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ITGA4—Crohn's disease	3.22e-05	0.000284	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL1B—Crohn's disease	3.21e-05	0.000283	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—PTGS2—Crohn's disease	3.19e-05	0.000282	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL3—Crohn's disease	3.14e-05	0.000277	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PTPN2—Crohn's disease	3.1e-05	0.000274	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CXCL8—Crohn's disease	3.1e-05	0.000274	CbGpPWpGaD
Glucosamine—IFNG—Immune System—RBX1—Crohn's disease	3.07e-05	0.000271	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—RASGRP1—Crohn's disease	3.03e-05	0.000268	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD79A—Crohn's disease	3.02e-05	0.000267	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL1B—Crohn's disease	2.97e-05	0.000262	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TAB1—Crohn's disease	2.97e-05	0.000262	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NOD2—Crohn's disease	2.92e-05	0.000258	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RSPO3—Crohn's disease	2.89e-05	0.000255	CbGpPWpGaD
Glucosamine—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.85e-05	0.000252	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL6—Crohn's disease	2.84e-05	0.000251	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—SMAD3—Crohn's disease	2.83e-05	0.00025	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL6—Crohn's disease	2.77e-05	0.000245	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—SOCS1—Crohn's disease	2.75e-05	0.000243	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SEL1L—Crohn's disease	2.74e-05	0.000242	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—Crohn's disease	2.72e-05	0.00024	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—STAT3—Crohn's disease	2.69e-05	0.000237	CbGpPWpGaD
Glucosamine—IFNG—Immune System—UBE2D1—Crohn's disease	2.69e-05	0.000237	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TYK2—Crohn's disease	2.66e-05	0.000235	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—Crohn's disease	2.61e-05	0.00023	CbGpPWpGaD
Glucosamine—IFNG—Immune System—RIPK2—Crohn's disease	2.61e-05	0.00023	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ITGA4—Crohn's disease	2.61e-05	0.00023	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—TYK2—Crohn's disease	2.59e-05	0.000229	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL3—Crohn's disease	2.54e-05	0.000224	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—JAK2—Crohn's disease	2.54e-05	0.000224	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR9—Crohn's disease	2.51e-05	0.000221	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	2.48e-05	0.000219	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL18—Crohn's disease	2.48e-05	0.000219	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—JAK2—Crohn's disease	2.47e-05	0.000218	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—IL6—Crohn's disease	2.46e-05	0.000218	CbGpPWpGaD
Glucosamine—IFNG—Immune System—RASGRP1—Crohn's disease	2.46e-05	0.000217	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD79A—Crohn's disease	2.45e-05	0.000216	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.44e-05	0.000216	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TAB1—Crohn's disease	2.41e-05	0.000212	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CD4—Crohn's disease	2.4e-05	0.000212	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL1B—Crohn's disease	2.38e-05	0.00021	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NOD2—Crohn's disease	2.36e-05	0.000209	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GPR65—Crohn's disease	2.33e-05	0.000206	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL6—Crohn's disease	2.32e-05	0.000205	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—STAT3—Crohn's disease	2.31e-05	0.000204	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—IL1B—Crohn's disease	2.24e-05	0.000198	CbGpPWpGaD
Glucosamine—IFNG—Immune System—SOCS1—Crohn's disease	2.23e-05	0.000197	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL6—Crohn's disease	2.2e-05	0.000194	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL2RA—Crohn's disease	2.2e-05	0.000194	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.17e-05	0.000192	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—IL6—Crohn's disease	2.12e-05	0.000188	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.08e-05	0.000183	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CRP—Crohn's disease	2.07e-05	0.000183	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL18—Crohn's disease	2.01e-05	0.000177	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TLR4—Crohn's disease	1.99e-05	0.000176	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	1.96e-05	0.000173	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ICAM1—Crohn's disease	1.91e-05	0.000168	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—Crohn's disease	1.88e-05	0.000166	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TYK2—Crohn's disease	1.85e-05	0.000163	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL2RA—Crohn's disease	1.78e-05	0.000157	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—JAK2—Crohn's disease	1.76e-05	0.000156	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—Crohn's disease	1.74e-05	0.000154	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—SMAD3—Crohn's disease	1.73e-05	0.000153	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CRP—Crohn's disease	1.68e-05	0.000148	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR6—Crohn's disease	1.66e-05	0.000147	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.62e-05	0.000143	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—Crohn's disease	1.61e-05	0.000142	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TLR4—Crohn's disease	1.61e-05	0.000142	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TYK2—Crohn's disease	1.55e-05	0.000137	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ICAM1—Crohn's disease	1.54e-05	0.000136	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	1.53e-05	0.000135	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.52e-05	0.000134	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RBX1—Crohn's disease	1.5e-05	0.000133	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—JAK2—Crohn's disease	1.48e-05	0.00013	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTGER4—Crohn's disease	1.46e-05	0.000129	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFNG—Crohn's disease	1.45e-05	0.000128	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	1.41e-05	0.000125	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD4—Crohn's disease	1.4e-05	0.000124	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.39e-05	0.000123	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—UBE2D1—Crohn's disease	1.32e-05	0.000116	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—Crohn's disease	1.3e-05	0.000115	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—STAT3—Crohn's disease	1.29e-05	0.000114	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL1B—Crohn's disease	1.29e-05	0.000114	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RIPK2—Crohn's disease	1.28e-05	0.000113	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—Crohn's disease	1.27e-05	0.000112	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TYK2—Crohn's disease	1.25e-05	0.000111	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL3—Crohn's disease	1.25e-05	0.00011	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RASGRP1—Crohn's disease	1.2e-05	0.000106	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—MTMR3—Crohn's disease	1.2e-05	0.000106	CbGpPWpGaD
Glucosamine—IFNG—Immune System—JAK2—Crohn's disease	1.2e-05	0.000106	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD4—Crohn's disease	1.13e-05	0.0001	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TYK2—Crohn's disease	1.13e-05	9.99e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TNF—Crohn's disease	1.12e-05	9.89e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SOCS1—Crohn's disease	1.09e-05	9.64e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	1.09e-05	9.61e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—STAT3—Crohn's disease	1.08e-05	9.57e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—JAK2—Crohn's disease	1.08e-05	9.53e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1B—Crohn's disease	1.05e-05	9.25e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SMAD3—Crohn's disease	9.42e-06	8.32e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—FADS1—Crohn's disease	9.34e-06	8.25e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—MTMR3—Crohn's disease	9.25e-06	8.17e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—Crohn's disease	9.04e-06	7.98e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—STAT3—Crohn's disease	8.78e-06	7.76e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GPX4—Crohn's disease	8.75e-06	7.73e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL2RA—Crohn's disease	8.73e-06	7.7e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GCKR—Crohn's disease	8.45e-06	7.46e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—STAT3—Crohn's disease	7.92e-06	7e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—Crohn's disease	7.57e-06	6.69e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—FADS1—Crohn's disease	7.21e-06	6.36e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GPX4—Crohn's disease	6.75e-06	5.96e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GCKR—Crohn's disease	6.52e-06	5.76e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TYK2—Crohn's disease	6.15e-06	5.43e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—Crohn's disease	6.14e-06	5.42e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—JAK2—Crohn's disease	5.86e-06	5.18e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—Crohn's disease	5.54e-06	4.89e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL8—Crohn's disease	5.35e-06	4.73e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.66e-06	4.11e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—STAT3—Crohn's disease	4.3e-06	3.8e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.08e-06	3.6e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—Crohn's disease	3.01e-06	2.65e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALB—Crohn's disease	2.69e-06	2.37e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS2—Crohn's disease	2.35e-06	2.08e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALB—Crohn's disease	2.07e-06	1.83e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS2—Crohn's disease	1.82e-06	1.6e-05	CbGpPWpGaD
